Narodny Onkologicky Ustav — Clinical Trial Site

41 Registered trials

22 Currently recruiting

Organisation

Narodny Onkologicky Ustav

Location

Bratislava, Slovakia

Identifier

ORG-100026552

Address

Klenova 1, Nove Mesto, 831 01, Slovakia

Departments

#2011:Oddelenie onkohematológie II
#2400: Oddelenie ambulantnej chemoterapie I
1450: II. Onkologická klinika LFUK a NOÚ | Klinika klinickej onkológie SZU a NOÚ
3241:II. Onkologická klinika LFUK a NOÚ | Klinika klinickej onkológie SZU a NOÚ
6701: Klinika onkohematologie
Clinic of Clinical Oncology
Clinical Oncology
Clinical Oncology Department G
Department of Clinical Oncology
Department of Clinical Oncology E
Department of Onco-hematology
Dept Med Oncology
II onkologicka klinika LF UK a NOU_Klinika klinickej onkologie SZU a NOU
II. Oncology Clinic
II. onkologická klinika LF UK a NOÚ,Oddelenie klinickej onkológie D
II. Onkologicka klinika LFUK a NOU
II. Onkologicka klinika LFUK a NOU, Klinicka klinickej onkologie SZU a NOU
Klinika onkohematológie LFUK a NOU
Medical Oncology
N/A
NA
Národný Onkologický Ústav
Oddelenie klinickej onkologie D
Oddelenie klinickej onkologie E
Oddelenie klinickej onkológie G
Oddelenie Onkohematologie II
Oncohematology
Oncohematology Clinic LFUK and NOÚ
Oncology
Outpatient clinical oncology care in hospital
Prsníkové centrum

Clinical trials at this site (41)

Search interface

A Study to Learn About the Investigational Medicine Called PF-06821497 (mevrometostat) in Men with mCRPC Who Were Previously Treated with Ab… Ended

2024-511650-50-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-01-17
A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC Ended

2023-504753-12-00 Lung Cancer, Non-Small Cell 5 2024-10-01
A randomized, open-label, multi-center phase III trial comparing tisagenlecleucel to standard of care in adult participants with relapsed or… Ended

2023-503452-27-00 Adult patients with follicular B-cell non-Hodgkin lymph 5 2024-01-02
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
A Randomized Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults … Ended

2023-503640-14-00 Newly diagnosed Philadelphia-negative B-cell precursor 5 2022-02-17
A clinical study to assess the efficacy of alpelisib plus fulvestrant in participants with HR-positive, HER2-negative, advanced breast cance… Ended

2023-509133-39-00 Hormone receptor positive, HER2-negative advanced breas 5 2021-11-29
A randomized, double-blind, Phase III Study of AZD9833 plus CDK4/6 inhibitor in patients with metastatic breast cancer with detectable ESR1 … Ended

2023-503990-39-00 Estrogen Receptor-Positive, HER-2 negative Advanced Bre 5 2021-09-30
Phase 3 Randomized Study of Talazoparib with Enzalutamide in Men with DDR Gene Mutated mCSPC Ended

2024-510809-28-00 Metastatic Castration-sensitive Prostate Cancer 5 2021-09-27
PSMAfore: A phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therap… Ended

2023-507772-50-00 PSMA-positive metastatic castration-resistant prostate 5 2021-06-16
A Randomised, Double-Blind, Phase III Study of AZD9833 plus Palbociclib versus Anastrozole plus Palbociclib in Patients with ER-Positive HER… Ended

2023-503995-26-00 Estrogen Receptor-Positive, HER2-Negative Advanced Brea 5 2021-05-11
EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study Ended

2023-508478-27-00 Advanced stage Hodgkin Lymphoma 4 2019-07-30
This study is being done to test the effectiveness and safety of an investigational drug called acalabrutinib (ACP-196) when taken with alre… Ended

2023-509349-11-00 Previously untreated Chronic Lymphocytic Leukemia Witho 5 2019-03-22
A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small… Halted

2023-503298-39-00 Metastatic Non-Small Cell Lung Cancer (mNSCLC) 5 2024-06-13
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER 4 2024-11-12
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 Reversal of anticoagulation effect in patients on a FXa 5
A Phase I Study of INCB099280 in Combination With Ipilimumab in Participants With Selected Solid Tumors Ended

2023-503243-34-00 Solid tumor 3
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5